LeddarTech Showcasing Its Award-Winning Sensor Fusion and Perception Software and High-Performance Products That Enable ADAS and AD at Tech.AD Berlin on March 26-28, 2023
QUEBEC CITY, March 08, 2023 (GLOBE NEWSWIRE) -- LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD software technology, is pleased to announce its participation at Automotive Tech.AD Berlin at the Titanic Chaussee Hotel Berlin. LeddarTech is a Competence Partner of Tech.AD and will exhibit its technology; Pierre Olivier, CTO of LeddarTech, will be an event presenter.
LeddarTech’s LeddarVision Showcase (Booth # 6)
LeddarVision™ is a high-performance, low-cost, hardware-agnostic low-level sensor fusion and perception solution for automotive and off-road industrial ADAS and AD applications.
Experience: The Award-Winning LeddarVision Interactive Dashboard Demonstration
This dashboard enables delegates to witness the LeddarVision software’s extraordinarily high performance at various levels of autonomy in various scenarios, such as extreme weather conditions.
Pre-arrange a meeting for product demonstrations, media and industry analyst interviews or investor discussions.
Witness the European unveiling of LeddarTech’s newest products!
The LeddarVision Front-View (LVF) family of automotive software products addresses the challenges faced when developing Level 2/2+ ADAS applications, such as solving safety issues and finding scalable fusion and perception software that offers high performance at a low cost. These two distinct products are comprehensive low-level fusion and perception software stacks that optimally combine sensor modalities for Level 2/2+ ADAS applications achieving a 5-star NCAP 2025/GSR 2022 rating.
- LeddarVision Front (Entry-Level) (LVF-E): This product pushes the performance envelope, doubling the effective range of the sensors and enabling, for the first time, a solution with only three sensors. Low-cost sensing, together with efficient implementation on the TDA4L platform, achieves the lowest system cost for L2/L2+ entry-level ADAS.
- LeddarVision Front (High-End)(LVF-H): With sensor configuration extended to 1V5R based on a single 3-megapixel 120-degree camera and five radars, the LVF-H stack extends the perception support to highway assist applications, including 160 km/h adaptive cruise control, 200-meter range and semi-automated lane change. These plus other features, including low-cost sensing, achieve economical front-view L2/L2+ premium ADAS.
Special Feature: LeddarVision Surround (LVS-2+). This product efficiently extends the LVF front-view product family 1VxR sensor configuration to a 5V5R configuration, enhancing support to traffic jam assist (TJA) and highway assist (HWA) applications. It also enables applications such as automated lane change, overtaking and extended speed range adaptive cruise control (ACC). Furthermore, the LVS-2+ supports premium surround-view L2/L2+ ADAS highway assistance and 5-star NCAP 2025/GSR 2022 safety applications.
LeddarTech Presents: On March 27 (11:30 to 12:00 CET), the CTO of LeddarTech, Pierre Olivier, a Tech.AD favorite for his engaging and thoughtful presentations, will deliver a keynote presentation entitled: “Solving Critical Issues Affecting the Safety of ADAS to Accelerate AD Adoption.” This presentation will unveil some critical issues surrounding ADAS and AD safety and performance that are evident today, why they affect customer confidence, and how they can be addressed to accelerate greater safety and autonomy.
About Automotive Tech.AD Berlin
10th Anniversary: This award-winning AD & ADAS conference is designed to bring advanced engineers and automotive experts from OEMs, Tier 1s, suppliers and leading research institutes to the next level. Join over 600 of the most influential autonomous vehicle experts and executives in Berlin.
About LeddarTech
LeddarTech, a global software company founded in 2007, develops and provides comprehensive perception solutions that enable the deployment of ADAS and autonomous driving applications. LeddarTech’s automotive-grade software applies AI and computer vision algorithms to generate highly accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is leveraged by OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle solutions.
LeddarTech is responsible for several remote-sensing innovations, with over 150 patents granted or applied for that enhance ADAS and AD capabilities. Reliable perception is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to become the most widely adopted sensor fusion and perception software solution.
Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.
Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com
Investor relations contact and website:InvestorRelations@leddartech.com
https://investors.leddartech.com/
Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e8d665fc-e659-482b-bde7-9528b740e81a
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares23.4.2024 22:17:37 CEST | Press release
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of ADSs offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Goldman Sachs and Leerink Partners are acting as lead joint book-running managers for the proposed offering. Evercore ISI, Guggenheim Securities and BMO Capital Markets are also acting as joint book-running mana
Interoil's Annual Statement of Reserves 2023 released23.4.2024 21:35:25 CEST | Press release
Oslo, 23 April 2024 Interoil Exploration and Production ASA today released the Annual Statement of Reserves for 2023. Please find the document attached. The report is also available on the company website. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act and is prepared in accordance with Oslo Stock Exchange's Listing and disclosure requirements for oil and natural gas companies. + + + Please direct any question to ir@interoil.no Interoil Exploration and Production ASA is a Norwegian based exploration and production company - listed on the Oslo Stock Exchange - with focus on Latin America. The Company is operator and license holder of several production and exploration assets in Colombia and Argentina. Interoil currently employs approximately 50 people and is headquartered in Oslo. Attachment Interoil reserves statement 2023
Nokia Corporation: Repurchase of own shares on 23.04.202423.4.2024 21:30:00 CEST | Press release
Nokia Corporation Stock Exchange Release 23 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 23.04.2024 Espoo, Finland – On 23 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6153.40CEUX--BATE--AQEU--TQEX--Total385,6153.40 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors23.4.2024 19:42:34 CEST | Press release
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that is often unresectable and commonly diagnosed in the late stages of disease Novartis, a leader in radioligand therapy (RLT), is investigating a portfolio of RLTs to treat a broad range of cancers, including GEP-NETs, lung, prostate, breast, colon, brain and pancreatic cancers Basel, April 23, 2024 – Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera® (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut NETs. This approval makes Lutathera the first therapy specifically reviewed and appro
Grant of warrants23.4.2024 19:20:21 CEST | Press release
23 April 2024 Announcement no. 9 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has resolved, in accordance with the annual general meeting’s resolution on April 27, 2023, to issue a total of 4,000,000 warrants to members of the Executive Management. Each warrant grants the holder the right to subscribe for one share in BioPorto. The exercise price is DKK 1.23 per share, corresponding to the closing price today on Nasdaq Copenhagen. The warrants are issued in accordance with section 18 a of the Articles of Association. Half of the warrants vest over a 2-year period, and the remaining half upon completion of a qualified capital raise in the Company with terms of qualification (including timing and amount of proceeds) to be defined by the Board of Directors. The warrants are otherwise subject to the Company’s incentive warrant program as included in Appendix 1 o